ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

ARID1A is a key component of the SWI/SNF chromatin remodeling complexes which is important for the maintaining of biological processes of cells. Recent studies had uncovered the potential role of ARID1A alterations or expression loss in the therapeutic sensitivity of cancers, but the studies in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Dantong, Teng, Fei, Xing, Puyuan, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555283/
https://www.ncbi.nlm.nih.gov/pubmed/34715776
http://dx.doi.org/10.1186/s10020-021-00400-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555283/
https://www.ncbi.nlm.nih.gov/pubmed/34715776
http://dx.doi.org/10.1186/s10020-021-00400-5

Ejemplares similares